BeyondSpring Pharmaceuticals to Present Today at 4th Annual Cancer Biopartnering & Investment Forum in NYC
24 févr. 2016 08h30 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Feb. 24, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals’ Data Indicating Plinabulin Enhances Immune Response Provides Basis for Planned Phase I/II Combination Trial in NSCLC
08 févr. 2016 08h30 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Feb. 08, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals to Present at 18th Annual BIO CEO & Investor Conference
03 févr. 2016 08h30 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Feb. 03, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals to Present at 8th Annual Biotech Showcase
07 janv. 2016 08h00 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Jan. 07, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals and Fred Hutchinson Cancer Research Center Enter Collaboration Agreement
06 janv. 2016 09h51 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Jan. 06, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals to Present Plinabulin-Immune System Interactions at AACR’s 2016 Tumor Microenvironment Special Conference
05 janv. 2016 10h32 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Jan. 05, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase...
BeyondSpring Pharmaceuticals Granted CTA by CFDA to Initiate China Arm of Global Phase III Trial of Lead Asset Plinabulin
21 déc. 2015 16h00 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Dec. 21, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies,...
BeyondSpring Data Demonstrating Activity of Plinabulin in Kras-Mutant Tumors Presented at AACR-NCI-EORTC International Conference 2015
17 nov. 2015 08h00 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Nov. 17, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring Announces Appointments of Dr. Ramon Mohanlal as Chief Medical Officer and Robert Dickey IV as Chief Financial Officer
30 oct. 2015 07h00 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Oct. 30, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring Announces Positive Follow-Up Results for Phase 2 Trial of Plinabulin in Advanced NSCLC at WCLC 2015
15 sept. 2015 10h19 HE
|
BeyondSpring Pharmaceuticals
NEW YORK, Sept. 15, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...